Shukra Pharma - SHUKRAPHAR, 524632 corporate action history

Shukra Pharmaceuticals Ltd.

BSE: 524632 |

Expensive Star

Download real time

66.50 -0.49 (-0.73%)

New 52W High in past week

2.2M

NSE+BSE Volume

BSE 12 Oct, 2026 3:31 PM (IST)

Bonus history for Shukra Pharma

Shukra Pharma has given 1 bonus since April 19, 2024. The last Bonus that Shukra Pharma anoununced was in the ratio 3:1 with ex-date of April 19, 2024.

Ex-Date	Bonus Ratio	Record Date
19 Apr 2024	3:1	20 Apr 2024

See all forthcoming Bonus and split

Split history for Shukra Pharma

Shukra Pharma has split the face value 1 time since March 21, 2025. Shukra Pharma had last split the face value of its shares from ₹10 to ₹1 in 2025.The share has been quoting on an ex-split basis from March 21, 2025.

Ex-Date	Old FV	New FV	Record Date
21 Mar 2025	10	1	21 Mar 2025

See all forthcoming Bonus and split

Dividend history for Shukra Pharma

Shukra Pharma has declared 7 dividends since Aug. 31, 2018.

In the past 12 months, Shukra Pharma has declared an equity dividend amounting to ₹0.01 per share.

At the current share price of ₹66.5000, Shukra Pharma's dividend yield is 0.02%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
21 Sep 2026	0.010	FINAL	21 Sep 2026	Equity Share
18 Sep 2025	0.010	FINAL	18 Sep 2025	Equity Share
23 Sep 2024	1.000	FINAL	-	Equity Share
15 Sep 2023	0.500	FINAL	-	Equity Share
22 Sep 2022	0.500	FINAL	-	Equity Share
19 Sep 2019	0.500	FINAL	-	Equity Share
31 Aug 2018	0.500	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Shukra Pharma

The latest board meeting for Shukra Pharma took place on 22 Aug 2026, for the purpose of A.G.M.

Ex-Date	Purpose	Notes
22 Aug 2026	A.G.M.	-
12 Aug 2026	Quarterly Results	-
10 Jun 2026	Others	Inter-alia, to consider 1. Ratification of Approval for member's resolution passed in the EGM. 2. To approve draft of notice of postal ballot. 3. Other business matters.
07 May 2026	Audited Results & Final Dividend	-
16 Mar 2026	Others	Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters.
04 Feb 2026	Quarterly Results	(Revised)
13 Nov 2025	Quarterly Results	-
03 Oct 2025	Others	Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters.
13 Aug 2025	Quarterly Results	-
04 Jun 2025	Final Dividend	-

See all Board Meetings for Shukra Pharma

Rights history for Shukra Pharma

Shukra Pharma issued rights 1 time since Feb. 2, 2023. Shukra Pharma had last issued Rights shares of ₹10.0/- in the ratio of 6.0:1.0 @ premium of ₹10.0/- on Feb. 2, 2023.

Ex-Date	Ratio	Face Value	Premium	Record Date
02 Feb 2023	6.0:1.0	10.0	10.0	02 Feb 2023

See all Rights History for Shukra Pharma

Is Shukra Pharmaceuticals Ltd. worth buying?

65 Votes:

Buy 73.85%

Sell 13.85%

Hold 12.31%